Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan
Objectives To identify the prognosis of patients with non‐urothelial carcinoma of the upper urinary tract and compare it with that of patients with urothelial carcinoma. Methods We used hospital‐based cancer registry data in Japan to extract histologically confirmed non‐urothelial carcinoma and urot...
Gespeichert in:
| Veröffentlicht in: | International journal of urology 2021-01, Vol.28 (1), p.54-60 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 60 |
|---|---|
| container_issue | 1 |
| container_start_page | 54 |
| container_title | International journal of urology |
| container_volume | 28 |
| creator | Nagumo, Yoshiyuki Kawai, Koji Kojima, Takahiro Shiga, Masanobu Kojo, Kosuke Tanaka, Ken Kandori, Shuya Kimura, Tomokazu Kawahara, Takashi Okuyama, Ayako Higashi, Takahiro Nishiyama, Hiroyuki |
| description | Objectives
To identify the prognosis of patients with non‐urothelial carcinoma of the upper urinary tract and compare it with that of patients with urothelial carcinoma.
Methods
We used hospital‐based cancer registry data in Japan to extract histologically confirmed non‐urothelial carcinoma and urothelial carcinoma cases of the upper urinary tract diagnosed in 2008–2009. We estimated the 5‐year overall survival by a Kaplan–Meier analysis. The Cox proportional hazards regression analysis was used to evaluate prognostic factors.
Results
A total of 2567 upper urinary tract cancer patients with confirmed histological subtypes were identified. The most common histology of non‐urothelial carcinoma was squamous cell carcinoma (n = 88, 3.4%) followed by adenocarcinoma (n = 33, 1.3%) and small cell carcinoma (n = 10, 0.4%). The proportion of advanced stage in the squamous cell carcinoma patients was significantly higher than that in the urothelial carcinoma patients (P = 0.003). In stage IV, the proportion of patients who received a combination of surgery + chemotherapy in the urothelial carcinoma group was higher than that in the non‐urothelial carcinoma group (34% vs 16%, respectively). The 5‐year overall survival rates of the non‐urothelial carcinoma patients at stages I–III and stage IV were significantly worse than those of the urothelial carcinoma patients (P = 0.003, P |
| doi_str_mv | 10.1111/iju.14393 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_33167076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2459349666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4433-237c15e180b3143e9d381a28c54034f710aa9f93809472ce1eb83e02b58a37d73</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EosPAghdAltiAUFr_Jba7q0b8tKoEC7qOHMdpPUrsYDtCs2PFmmfkSbjDDF0gIeGNrevvHN17D0LPKTmlcM78djmlgmv-AK2oEKxiRLCHaEU01ZWikp2gJzlvCaGcUfUYnXBOG0lks0LfP6V4G2Iu3mI_zcYWHAccYvj57ceSYrlzozcjtiZZH-Jk9r9QxMs8u4SX5INJO1wSCM_xRTDjLvu8h-5inn0xI_h0JrseLIIFSXK3PhfQ9KYY7AO-MrMJT9GjwYzZPTvea3Tz7u3nzYfq-uP7y83FdWWF4LxiXFpaO6pIx2Fgp3uuqGHK1oJwMUhKjNGD5opoIZl11HWKO8K6Whkue8nX6NXBd07xy-JyaSefrRtHE1xccstErbnQTdMA-vIvdBuXBBPuKdlIykSjgHp9oGyKOSc3tHPyE-ykpaTdh9NCOO3vcIB9cXRcusn19-SfNAB4cwC-ui4O2XoHK7vHCCG1krWiGl4Q5Rqp_6c3kEXxMWziEgpIz45SP7rdv1tuL69uDr3_AjPAu7M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476712468</pqid></control><display><type>article</type><title>Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Nagumo, Yoshiyuki ; Kawai, Koji ; Kojima, Takahiro ; Shiga, Masanobu ; Kojo, Kosuke ; Tanaka, Ken ; Kandori, Shuya ; Kimura, Tomokazu ; Kawahara, Takashi ; Okuyama, Ayako ; Higashi, Takahiro ; Nishiyama, Hiroyuki</creator><creatorcontrib>Nagumo, Yoshiyuki ; Kawai, Koji ; Kojima, Takahiro ; Shiga, Masanobu ; Kojo, Kosuke ; Tanaka, Ken ; Kandori, Shuya ; Kimura, Tomokazu ; Kawahara, Takashi ; Okuyama, Ayako ; Higashi, Takahiro ; Nishiyama, Hiroyuki</creatorcontrib><description>Objectives
To identify the prognosis of patients with non‐urothelial carcinoma of the upper urinary tract and compare it with that of patients with urothelial carcinoma.
Methods
We used hospital‐based cancer registry data in Japan to extract histologically confirmed non‐urothelial carcinoma and urothelial carcinoma cases of the upper urinary tract diagnosed in 2008–2009. We estimated the 5‐year overall survival by a Kaplan–Meier analysis. The Cox proportional hazards regression analysis was used to evaluate prognostic factors.
Results
A total of 2567 upper urinary tract cancer patients with confirmed histological subtypes were identified. The most common histology of non‐urothelial carcinoma was squamous cell carcinoma (n = 88, 3.4%) followed by adenocarcinoma (n = 33, 1.3%) and small cell carcinoma (n = 10, 0.4%). The proportion of advanced stage in the squamous cell carcinoma patients was significantly higher than that in the urothelial carcinoma patients (P = 0.003). In stage IV, the proportion of patients who received a combination of surgery + chemotherapy in the urothelial carcinoma group was higher than that in the non‐urothelial carcinoma group (34% vs 16%, respectively). The 5‐year overall survival rates of the non‐urothelial carcinoma patients at stages I–III and stage IV were significantly worse than those of the urothelial carcinoma patients (P = 0.003, P < 0.001, respectively). In multivariate analyses, age ≥73 years, advanced stage (stage IV), tumor location (ureter) and the presence of non‐urothelial carcinoma histology were independent poor prognosis factors.
Conclusion
The prognosis of non‐urothelial carcinoma patients is worse than that of urothelial carcinoma patients, especially for non‐urothelial carcinoma patients at stage IV. More effective systemic therapies are required to improve these patients’ oncological outcomes.</description><identifier>ISSN: 0919-8172</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.14393</identifier><identifier>PMID: 33167076</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Adenocarcinoma ; Aged ; Cancer ; Carcinoma, Transitional Cell - epidemiology ; Carcinoma, Transitional Cell - therapy ; Chemotherapy ; Histology ; Hospitals ; hospital‐based cancer registry ; Humans ; Japan - epidemiology ; Kaplan-Meier Estimate ; Life Sciences & Biomedicine ; Medical prognosis ; non‐urothelial carcinoma ; overall survival ; Patients ; Population-based studies ; population‐based study ; Prognosis ; Proportional Hazards Models ; Registries ; Retrospective Studies ; Science & Technology ; Squamous cell carcinoma ; Surgery ; upper urinary tract ; Ureter ; Ureteral Neoplasms - epidemiology ; Ureteral Neoplasms - therapy ; Urinary Tract ; Urogenital system ; Urologic Neoplasms - epidemiology ; Urologic Neoplasms - therapy ; Urology & Nephrology ; Urothelial carcinoma</subject><ispartof>International journal of urology, 2021-01, Vol.28 (1), p.54-60</ispartof><rights>2020 The Japanese Urological Association</rights><rights>2020 The Japanese Urological Association.</rights><rights>2021 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>6</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000587581900001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c4433-237c15e180b3143e9d381a28c54034f710aa9f93809472ce1eb83e02b58a37d73</citedby><cites>FETCH-LOGICAL-c4433-237c15e180b3143e9d381a28c54034f710aa9f93809472ce1eb83e02b58a37d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fiju.14393$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fiju.14393$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33167076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nagumo, Yoshiyuki</creatorcontrib><creatorcontrib>Kawai, Koji</creatorcontrib><creatorcontrib>Kojima, Takahiro</creatorcontrib><creatorcontrib>Shiga, Masanobu</creatorcontrib><creatorcontrib>Kojo, Kosuke</creatorcontrib><creatorcontrib>Tanaka, Ken</creatorcontrib><creatorcontrib>Kandori, Shuya</creatorcontrib><creatorcontrib>Kimura, Tomokazu</creatorcontrib><creatorcontrib>Kawahara, Takashi</creatorcontrib><creatorcontrib>Okuyama, Ayako</creatorcontrib><creatorcontrib>Higashi, Takahiro</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><title>Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan</title><title>International journal of urology</title><addtitle>INT J UROL</addtitle><addtitle>Int J Urol</addtitle><description>Objectives
To identify the prognosis of patients with non‐urothelial carcinoma of the upper urinary tract and compare it with that of patients with urothelial carcinoma.
Methods
We used hospital‐based cancer registry data in Japan to extract histologically confirmed non‐urothelial carcinoma and urothelial carcinoma cases of the upper urinary tract diagnosed in 2008–2009. We estimated the 5‐year overall survival by a Kaplan–Meier analysis. The Cox proportional hazards regression analysis was used to evaluate prognostic factors.
Results
A total of 2567 upper urinary tract cancer patients with confirmed histological subtypes were identified. The most common histology of non‐urothelial carcinoma was squamous cell carcinoma (n = 88, 3.4%) followed by adenocarcinoma (n = 33, 1.3%) and small cell carcinoma (n = 10, 0.4%). The proportion of advanced stage in the squamous cell carcinoma patients was significantly higher than that in the urothelial carcinoma patients (P = 0.003). In stage IV, the proportion of patients who received a combination of surgery + chemotherapy in the urothelial carcinoma group was higher than that in the non‐urothelial carcinoma group (34% vs 16%, respectively). The 5‐year overall survival rates of the non‐urothelial carcinoma patients at stages I–III and stage IV were significantly worse than those of the urothelial carcinoma patients (P = 0.003, P < 0.001, respectively). In multivariate analyses, age ≥73 years, advanced stage (stage IV), tumor location (ureter) and the presence of non‐urothelial carcinoma histology were independent poor prognosis factors.
Conclusion
The prognosis of non‐urothelial carcinoma patients is worse than that of urothelial carcinoma patients, especially for non‐urothelial carcinoma patients at stage IV. More effective systemic therapies are required to improve these patients’ oncological outcomes.</description><subject>Adenocarcinoma</subject><subject>Aged</subject><subject>Cancer</subject><subject>Carcinoma, Transitional Cell - epidemiology</subject><subject>Carcinoma, Transitional Cell - therapy</subject><subject>Chemotherapy</subject><subject>Histology</subject><subject>Hospitals</subject><subject>hospital‐based cancer registry</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Kaplan-Meier Estimate</subject><subject>Life Sciences & Biomedicine</subject><subject>Medical prognosis</subject><subject>non‐urothelial carcinoma</subject><subject>overall survival</subject><subject>Patients</subject><subject>Population-based studies</subject><subject>population‐based study</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Science & Technology</subject><subject>Squamous cell carcinoma</subject><subject>Surgery</subject><subject>upper urinary tract</subject><subject>Ureter</subject><subject>Ureteral Neoplasms - epidemiology</subject><subject>Ureteral Neoplasms - therapy</subject><subject>Urinary Tract</subject><subject>Urogenital system</subject><subject>Urologic Neoplasms - epidemiology</subject><subject>Urologic Neoplasms - therapy</subject><subject>Urology & Nephrology</subject><subject>Urothelial carcinoma</subject><issn>0919-8172</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EosPAghdAltiAUFr_Jba7q0b8tKoEC7qOHMdpPUrsYDtCs2PFmmfkSbjDDF0gIeGNrevvHN17D0LPKTmlcM78djmlgmv-AK2oEKxiRLCHaEU01ZWikp2gJzlvCaGcUfUYnXBOG0lks0LfP6V4G2Iu3mI_zcYWHAccYvj57ceSYrlzozcjtiZZH-Jk9r9QxMs8u4SX5INJO1wSCM_xRTDjLvu8h-5inn0xI_h0JrseLIIFSXK3PhfQ9KYY7AO-MrMJT9GjwYzZPTvea3Tz7u3nzYfq-uP7y83FdWWF4LxiXFpaO6pIx2Fgp3uuqGHK1oJwMUhKjNGD5opoIZl11HWKO8K6Whkue8nX6NXBd07xy-JyaSefrRtHE1xccstErbnQTdMA-vIvdBuXBBPuKdlIykSjgHp9oGyKOSc3tHPyE-ykpaTdh9NCOO3vcIB9cXRcusn19-SfNAB4cwC-ui4O2XoHK7vHCCG1krWiGl4Q5Rqp_6c3kEXxMWziEgpIz45SP7rdv1tuL69uDr3_AjPAu7M</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Nagumo, Yoshiyuki</creator><creator>Kawai, Koji</creator><creator>Kojima, Takahiro</creator><creator>Shiga, Masanobu</creator><creator>Kojo, Kosuke</creator><creator>Tanaka, Ken</creator><creator>Kandori, Shuya</creator><creator>Kimura, Tomokazu</creator><creator>Kawahara, Takashi</creator><creator>Okuyama, Ayako</creator><creator>Higashi, Takahiro</creator><creator>Nishiyama, Hiroyuki</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>202101</creationdate><title>Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan</title><author>Nagumo, Yoshiyuki ; Kawai, Koji ; Kojima, Takahiro ; Shiga, Masanobu ; Kojo, Kosuke ; Tanaka, Ken ; Kandori, Shuya ; Kimura, Tomokazu ; Kawahara, Takashi ; Okuyama, Ayako ; Higashi, Takahiro ; Nishiyama, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4433-237c15e180b3143e9d381a28c54034f710aa9f93809472ce1eb83e02b58a37d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma</topic><topic>Aged</topic><topic>Cancer</topic><topic>Carcinoma, Transitional Cell - epidemiology</topic><topic>Carcinoma, Transitional Cell - therapy</topic><topic>Chemotherapy</topic><topic>Histology</topic><topic>Hospitals</topic><topic>hospital‐based cancer registry</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Kaplan-Meier Estimate</topic><topic>Life Sciences & Biomedicine</topic><topic>Medical prognosis</topic><topic>non‐urothelial carcinoma</topic><topic>overall survival</topic><topic>Patients</topic><topic>Population-based studies</topic><topic>population‐based study</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Science & Technology</topic><topic>Squamous cell carcinoma</topic><topic>Surgery</topic><topic>upper urinary tract</topic><topic>Ureter</topic><topic>Ureteral Neoplasms - epidemiology</topic><topic>Ureteral Neoplasms - therapy</topic><topic>Urinary Tract</topic><topic>Urogenital system</topic><topic>Urologic Neoplasms - epidemiology</topic><topic>Urologic Neoplasms - therapy</topic><topic>Urology & Nephrology</topic><topic>Urothelial carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nagumo, Yoshiyuki</creatorcontrib><creatorcontrib>Kawai, Koji</creatorcontrib><creatorcontrib>Kojima, Takahiro</creatorcontrib><creatorcontrib>Shiga, Masanobu</creatorcontrib><creatorcontrib>Kojo, Kosuke</creatorcontrib><creatorcontrib>Tanaka, Ken</creatorcontrib><creatorcontrib>Kandori, Shuya</creatorcontrib><creatorcontrib>Kimura, Tomokazu</creatorcontrib><creatorcontrib>Kawahara, Takashi</creatorcontrib><creatorcontrib>Okuyama, Ayako</creatorcontrib><creatorcontrib>Higashi, Takahiro</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagumo, Yoshiyuki</au><au>Kawai, Koji</au><au>Kojima, Takahiro</au><au>Shiga, Masanobu</au><au>Kojo, Kosuke</au><au>Tanaka, Ken</au><au>Kandori, Shuya</au><au>Kimura, Tomokazu</au><au>Kawahara, Takashi</au><au>Okuyama, Ayako</au><au>Higashi, Takahiro</au><au>Nishiyama, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan</atitle><jtitle>International journal of urology</jtitle><stitle>INT J UROL</stitle><addtitle>Int J Urol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>28</volume><issue>1</issue><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>0919-8172</issn><eissn>1442-2042</eissn><abstract>Objectives
To identify the prognosis of patients with non‐urothelial carcinoma of the upper urinary tract and compare it with that of patients with urothelial carcinoma.
Methods
We used hospital‐based cancer registry data in Japan to extract histologically confirmed non‐urothelial carcinoma and urothelial carcinoma cases of the upper urinary tract diagnosed in 2008–2009. We estimated the 5‐year overall survival by a Kaplan–Meier analysis. The Cox proportional hazards regression analysis was used to evaluate prognostic factors.
Results
A total of 2567 upper urinary tract cancer patients with confirmed histological subtypes were identified. The most common histology of non‐urothelial carcinoma was squamous cell carcinoma (n = 88, 3.4%) followed by adenocarcinoma (n = 33, 1.3%) and small cell carcinoma (n = 10, 0.4%). The proportion of advanced stage in the squamous cell carcinoma patients was significantly higher than that in the urothelial carcinoma patients (P = 0.003). In stage IV, the proportion of patients who received a combination of surgery + chemotherapy in the urothelial carcinoma group was higher than that in the non‐urothelial carcinoma group (34% vs 16%, respectively). The 5‐year overall survival rates of the non‐urothelial carcinoma patients at stages I–III and stage IV were significantly worse than those of the urothelial carcinoma patients (P = 0.003, P < 0.001, respectively). In multivariate analyses, age ≥73 years, advanced stage (stage IV), tumor location (ureter) and the presence of non‐urothelial carcinoma histology were independent poor prognosis factors.
Conclusion
The prognosis of non‐urothelial carcinoma patients is worse than that of urothelial carcinoma patients, especially for non‐urothelial carcinoma patients at stage IV. More effective systemic therapies are required to improve these patients’ oncological outcomes.</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>33167076</pmid><doi>10.1111/iju.14393</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0919-8172 |
| ispartof | International journal of urology, 2021-01, Vol.28 (1), p.54-60 |
| issn | 0919-8172 1442-2042 |
| language | eng |
| recordid | cdi_pubmed_primary_33167076 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adenocarcinoma Aged Cancer Carcinoma, Transitional Cell - epidemiology Carcinoma, Transitional Cell - therapy Chemotherapy Histology Hospitals hospital‐based cancer registry Humans Japan - epidemiology Kaplan-Meier Estimate Life Sciences & Biomedicine Medical prognosis non‐urothelial carcinoma overall survival Patients Population-based studies population‐based study Prognosis Proportional Hazards Models Registries Retrospective Studies Science & Technology Squamous cell carcinoma Surgery upper urinary tract Ureter Ureteral Neoplasms - epidemiology Ureteral Neoplasms - therapy Urinary Tract Urogenital system Urologic Neoplasms - epidemiology Urologic Neoplasms - therapy Urology & Nephrology Urothelial carcinoma |
| title | Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T07%3A43%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20impact%20of%20non%E2%80%90urothelial%20carcinoma%20of%20the%20upper%20urinary%20tract:%20Analysis%20of%20hospital%E2%80%90based%20cancer%20registry%20data%20in%20Japan&rft.jtitle=International%20journal%20of%20urology&rft.au=Nagumo,%20Yoshiyuki&rft.date=2021-01&rft.volume=28&rft.issue=1&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.14393&rft_dat=%3Cproquest_pubme%3E2459349666%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476712468&rft_id=info:pmid/33167076&rfr_iscdi=true |